Cure8 research brief
Many people with IBD try dietary changes to manage symptoms. This review summarizes what published adult studies report and points toward whole-food and Mediterranean-style patterns as commonly supported approaches.
Adults with Crohn's disease or ulcerative colitis, clinicians advising on diet, and researchers designing dietary trials in IBD.
This scoping review mapped dietary interventions studied for adults with Crohn’s disease and ulcerative colitis through 2025/updated May 2026 and included 49 eligible studies.
The authors found multiple dietary approaches reported to improve symptoms and disease activity indices but noted that symptom improvement did not always match changes in inflammatory biomarkers. The review highlights common features across diets: reduced processed foods and added sugars, and emphasis on whole foods, fruits, vegetables, and unsaturated fats.
The Mediterranean diet and whole-food principles are identified as well-supported and guideline-endorsed foundations. The authors call for more rigorous, standardized trials with disease-specific populations and mechanistic sub-studies, and attention to implementation and adherence support.
This brief summarizes the abstract provided by the journal (therapeutic advances in gastroenterology) and does not represent a review of the full set of source documents beyond that abstract.
This is a scoping review based on English-language studies through May 2026; it maps heterogenous interventions and variable outcome measures. The abstract notes a frequent mismatch between symptom relief and objective inflammatory biomarkers, and recommends standardized, rigorous future trials.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
RDW is a cheap, routinely measured blood parameter; if it reliably reflects IBD presence or activity, it could be an easy additional tool to help detect flares or support assessment without extra testing.
This trial tests whether pomegranate juice can lower fecal calprotectin, a commonly used marker of intestinal inflammation, in people with IBD in remission. If effective, such a dietary approach could be of interest to...
Vitamin D deficiency is common in people with IBD and may relate to disease activity, complications, and quality of life; understanding this link could influence monitoring and adjunctive care.
